受强制性开放获取政策约束的文章 - Abeer F. Alharbi了解详情
可在其他位置公开访问的文章：4 篇
CYP2C19 phenotype and body weight-guided voriconazole initial dose in infants and children after hematopoietic cell transplantation
T Takahashi, MA Mohamud, AR Smith, PA Jacobson, MM Jaber, ...
Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 00623-21, 2021
强制性开放获取政策： US National Institutes of Health
The role of genetic polymorphisms in endolysosomal ion channels TPC2 and P2RX4 in cancer pathogenesis, prognosis, and diagnosis: a genetic association in the UK Biobank
AF Alharbi, J Parrington
NPJ Genomic Medicine 6 (1), 58, 2021
强制性开放获取政策： UK Medical Research Council
Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion
AF Alharbi, RA Kratzke, J D’Cunha, MA Maddaus, K Sanghavi, ...
Cancer chemotherapy and pharmacology 83, 387-391, 2019
强制性开放获取政策： US National Institutes of Health
CYP51A1 polymorphism and voriconazole-associated hepatotoxicity in children undergoing hematopoietic cell transplant
T Takahashi, AR Smith, PA Jacobson, AF Alharbi, J Fisher, NT Rubin, ...
International Journal of Clinical Pharmacology and Therapeutics 59 (6), 442, 2021
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定